| Item Type | Name |
|
Concept
|
Psychology, Adolescent
|
|
Concept
|
Schizophrenic Psychology
|
|
Academic Article
|
Cognitive impairment in geriatric chronic schizophrenic patients: a cross-national study in New York and London.
|
|
Academic Article
|
A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.
|
|
Academic Article
|
Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial.
|
|
Academic Article
|
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
|
|
Academic Article
|
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
|
|
Academic Article
|
Limitations of controlled augmentation trials in schizophrenia.
|
|
Academic Article
|
Premorbid functioning and treatment response in recent-onset schizophrenia.
|
|
Academic Article
|
Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus.
|
|
Academic Article
|
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
|
|
Academic Article
|
Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia.
|
|
Academic Article
|
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
|
|
Academic Article
|
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
|
|
Academic Article
|
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
|
|
Academic Article
|
Assessment of dementia in elderly schizophrenics with structured rating scales.
|
|
Academic Article
|
Cortical cholinergic markers in schizophrenia.
|
|
Academic Article
|
Leukotomy and aging in chronic schizophrenia: a followup study 40 years after psychosurgery.
|
|
Academic Article
|
Convergence of cognitive and adaptive decline in late-life schizophrenia.
|
|
Academic Article
|
Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment.
|
|
Academic Article
|
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients.
|
|
Academic Article
|
Predictors of response to neuroleptic treatment in schizophrenia.
|
|
Academic Article
|
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
|
|
Academic Article
|
Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment.
|
|
Academic Article
|
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
|
|
Academic Article
|
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms.
|
|
Academic Article
|
The cost of cognitive impairment in schizophrenia.
|
|
Academic Article
|
Serotonin function and treatment response to clozapine in schizophrenic patients.
|
|
Academic Article
|
Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
|
|
Academic Article
|
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
|
|
Academic Article
|
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
|
|
Academic Article
|
Dopamine in schizophrenia: a review and reconceptualization.
|
|
Academic Article
|
A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia.
|
|
Academic Article
|
Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder.
|
|
Academic Article
|
Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance.
|
|
Academic Article
|
Time course and clinical predictors of treatment response in schizophrenia.
|
|
Academic Article
|
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
|
|
Academic Article
|
Age-related differences in formal thought disorder in chronically hospitalized schizophrenic patients: a cross-sectional study across nine decades.
|
|
Academic Article
|
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
|
|
Academic Article
|
Impaired reading comprehension and mathematical abilities in male adolescents with average or above general intellectual abilities are associated with comorbid and future psychopathology.
|
|
Academic Article
|
Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.
|
|
Academic Article
|
Social-Adaptive Functioning Evaluation (SAFE): a rating scale for geriatric psychiatric patients.
|
|
Academic Article
|
The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients.
|
|
Academic Article
|
The association between adaptive and cognitive deficits in geriatric chronic schizophrenic patients.
|
|
Academic Article
|
Symptom severity and cognitive impairment in chronically hospitalised geriatric patients with affective disorders.
|
|
Academic Article
|
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
|
|
Academic Article
|
Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine.
|
|
Academic Article
|
Memory functions in geriatric chronic schizophrenic patients: a neuropsychological study.
|
|
Academic Article
|
Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients.
|
|
Academic Article
|
Verbal fluency deficits in geriatric and nongeriatric chronic schizophrenic patients.
|
|
Academic Article
|
Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.
|
|
Academic Article
|
Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
|
|
Academic Article
|
Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
|
|
Academic Article
|
Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
|
|
Academic Article
|
The puzzle of processing speed, memory, and executive function impairments in schizophrenia: fitting the pieces together.
|
|
Academic Article
|
A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ.
|
|
Academic Article
|
Developmental Trajectories of Impaired Community Functioning in Schizophrenia.
|
|
Academic Article
|
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
|
|
Academic Article
|
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
|
|
Academic Article
|
Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
|
|
Academic Article
|
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
|
|
Academic Article
|
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial.
|
|
Academic Article
|
Short-term effects of coping skills training as adjunct to intensive therapy in adolescents.
|
|
Academic Article
|
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
|